Previous 10 | Next 10 |
A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 66.7% to $3.76 on volume of 298,289,429 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 70.5% to $0.1091 on volume of 172,174,410 shares Sientra Inc. (SIEN) rose 89.9% to $0.342 on volume of ...
A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 62.5% to $3.665 on volume of 269,509,234 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 64.1% to $0.105 on volume of 159,463,786 shares Sientra Inc. (SIEN) rose 119.4% to $0.395 on volume of...
2024-02-15 15:00:53 ET Summary Aurinia Pharmaceuticals Inc. stock price dropped 25% after underwhelming Q4 and full-year 2023 results. Sales of Lupkynis, indicated for lupus nephritis and the company's only commercial product, have failed to meet expectations. Aurinia has init...
2024-02-15 10:10:28 ET Aurinia Pharmaceuticals Inc. (AUPH) Q4 2023 Earnings Conference Call February 15, 2024 08:30 AM ET Company Participants Andrea Christopher - Head, Corporate Communications & Investor Relations Peter Greenleaf - Chief Executive Officer J...
2024-02-15 07:05:36 ET More on Aurinia Pharma Aurinia Pharmaceuticals: Sales Growth Would Help Buyout Potential Aurinia Pharmaceuticals: A Post Q3 Earnings Assessment Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M Aurini...
2024-02-15 06:02:11 ET Aurinia Pharma press release ( NASDAQ: AUPH ): Q4 GAAP EPS of -$0.19 misses by $0.03 . Revenue of $45.1M (+58.8% Y/Y) misses by $0.06M . Shares -3.6% PM. $350.7 million of cash, cash equivalents, restricted cash and investment...
Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...
Total net revenue was $45.1 million and $175.5 million, and net product revenue was $42.3 million and $158.5 million, for the fourth quarter and full year 2023, respectively $350.7 million of cash, cash equivalents, restricted cash and investments as of December 31, 2023 Reaffirms 2024 ne...
2024-02-14 10:53:15 ET More on Aurinia Pharma Aurinia Pharmaceuticals: Sales Growth Would Help Buyout Potential Aurinia Pharmaceuticals: A Post Q3 Earnings Assessment Aurinia Pharmaceuticals sees strong Q4 revenue growth, eyes cash flow positivity Aurinia Pha...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release 2023 fourth quarter and full year financial and operational results on Thursday, February 15, 2024, before markets open. Aurinia’s management team will host a conference call/webcast a...
News, Short Squeeze, Breakout and More Instantly...
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
Aurinia Pharmaceuticals Inc Website:
2024-05-02 10:45:03 ET Sabre Corp (SABR) SABR is trading UP for the last 5 days, and it at trading at $2.97 with volume of 2,856,606 and a one day change of $0.07 (2.42%). Sabre Corp has a 52-week low of 1.81 and a 52-week high of $5.77. The business's 50-day moving average price is...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Achieved $50.3 million in total net revenue and $48.1 million in net product revenue for the first quarter of 2024, representing year over year growth of approximately 46% and 40% respectively, and extending the trend of consistent growth in LUPKYNIS ® (voclosporin) sales Rapidly com...